GRALVSGTBP• 12 Months (Normalized)
GRAL vs GTBP (GRAIL Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GRAL Performance $136.57
+130.97%
GRAIL Inc.
Normalized Baseline0.00%
GTBP Performance $6.88
+1071.21%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-940.24 pts
GTBP outperforming by 940.24 percentage points
GRALGTBP
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GRAL GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | GRAL Price | GRAL Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $136.57 | +130.97% | $6.88 | +1071.21% | -940.24% |
| Sep 28, 2026 | $132.63 | +124.30% | $6.80 | +1058.43% | -934.13% |
| Sep 25, 2026 | $126.89 | +114.59% | $6.89 | +1073.76% | -959.17% |
| Sep 24, 2026 | $125.21 | +111.75% | $6.83 | +1063.54% | -951.79% |
| Sep 23, 2026 | $108.52 | +83.53% | $7.10 | +1109.54% | -1026.01% |
| Sep 22, 2026 | $108.52 | +83.53% | $- | - | |
| Sep 21, 2026 | $107.97 | +82.60% | $7.18 | +1123.17% | -1040.57% |
| Sep 18, 2026 | $80.77 | +36.60% | $7.16 | +1119.76% | -1083.16% |
| Sep 17, 2026 | $79.95 | +35.21% | $7.49 | +1175.98% | -1140.77% |
| Sep 16, 2026 | $75.11 | +27.03% | $7.81 | +1230.49% | -1203.46% |
| Sep 15, 2026 | $75.89 | +28.34% | $9.00 | +1433.22% | -1404.88% |
| Sep 14, 2026 | $75.53 | +27.74% | $11.63 | +1881.26% | -1853.52% |
| Sep 11, 2026 | $76.23 | +28.92% | $8.61 | +1366.78% | -1337.86% |
| Sep 10, 2026 | $77.56 | +31.17% | $6.18 | +952.81% | -921.64% |
| Sep 09, 2026 | $77.48 | +31.03% | $5.98 | +918.74% | -887.71% |
Page 1 of 17